Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alirocumab after acute coronary syndrome cardiovascular outcomes study
2011-005698-21Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of alirocumab in acute coronary syndrome (ACS), dyslipidemia, sponsored by Sanofi. Started Oct 2012; status: completed.
02
Drugs
alirocumab
03
Conditions
acute coronary syndrome (ACS)dyslipidemia
Beyond the preview
Go deeper on 2011-005698-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005698-21.